These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 30734364)
21. Hydroxyurea for ALL children with sickle cell anemia: What can we learn from Africa? Aygun B Pediatr Blood Cancer; 2020 Apr; 67(4):e28164. PubMed ID: 31925887 [No Abstract] [Full Text] [Related]
22. Treatment adherence in patients with sickle cell anemia. Drotar D J Pediatr; 2010 Mar; 156(3):350-1. PubMed ID: 20056235 [No Abstract] [Full Text] [Related]
23. Hydroxyurea for sickle-cell anaemia in Africa: mind the gap. Obaro SK Lancet Glob Health; 2015 Mar; 3(3):e124-5. PubMed ID: 25701988 [No Abstract] [Full Text] [Related]
24. Hydroxycarbamide use in young children with sickle-cell anaemia. Takahashi Y; Mori J; Tsubokura M; Matsumura T; Kami M Lancet; 2011 Nov; 378(9805):1777. PubMed ID: 22098851 [No Abstract] [Full Text] [Related]
25. Hydroxycarbamide use in young children with sickle-cell anaemia. Obaro SK; Inusa B; Telfer P Lancet; 2011 Nov; 378(9805):1777. PubMed ID: 22098850 [No Abstract] [Full Text] [Related]
26. Medical Neglect by Underprescription and Underutilization of Hydroxyurea in Children with Sickle Cell Disease. Rana S South Med J; 2016 Sep; 109(9):503-5. PubMed ID: 27598349 [No Abstract] [Full Text] [Related]
27. Expanding the role of hydroxyurea in children with sickle cell disease. Rogers ZR; Buchanan GR J Pediatr; 2004 Sep; 145(3):287-8. PubMed ID: 15343174 [No Abstract] [Full Text] [Related]
28. Hydroxyurea for sickle cell anemia. Bachmeyer C; Aractingi S; Lionnet F N Engl J Med; 2008 Jul; 359(1):98; author reply 98-9. PubMed ID: 18609755 [No Abstract] [Full Text] [Related]
29. [From Hemoglobin SS to SF: interest of hydroxyurea in the management of sickle cell disease in two Congolese children and review of the literature]. Nkashama GM; Wakamb GK; Mulangu AM; Nkashama GM; Kupa BK; Numbi OL Pan Afr Med J; 2015; 21():124. PubMed ID: 26327961 [TBL] [Abstract][Full Text] [Related]
32. Response to hydroxyurea among Kuwaiti patients with sickle cell disease and elevated baseline HbF levels. Adekile A; Menzel S; Gupta R; Al-Sharida S; Farag A; Haider M; Akbulut N; Mustafa N; Thein SL Am J Hematol; 2015 Jul; 90(7):E138-9. PubMed ID: 25851995 [No Abstract] [Full Text] [Related]
33. Therapy-related acute myelogenous leukemia in a hydroxyurea-treated patient with sickle cell anemia. Taylor JG; Darbari DS; Maric I; McIver Z; Arthur DC Ann Intern Med; 2011 Nov; 155(10):722-4. PubMed ID: 22084346 [No Abstract] [Full Text] [Related]
34. The rationale for using hydroxycarbamide in the treatment of sickle cell disease. Rees DC Haematologica; 2011 Apr; 96(4):488-91. PubMed ID: 21454878 [No Abstract] [Full Text] [Related]
36. Hydroxyurea use in patients with sickle cell disease in a Medicaid population. Ritho J; Liu H; Hartzema AG; Lottenberg R Am J Hematol; 2011 Oct; 86(10):888-90. PubMed ID: 21922530 [No Abstract] [Full Text] [Related]
37. Sickle cell patients find a brand New World. Noonan SS N J Med; 1999 Aug; 96(8):23-5. PubMed ID: 10457727 [TBL] [Abstract][Full Text] [Related]
38. New option for primary stroke prevention in sickle cell anaemia. DeBaun MR; Kirkham FJ Lancet; 2016 Feb; 387(10019):626-627. PubMed ID: 26670618 [No Abstract] [Full Text] [Related]